VC
NVO

Veracity Capital’s Novo Nordisk NVO Stock Holding History

Veracity Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,473
Closed -$242K – 257
2025
Q2 		$242K Sell
3,473
-142
-4% -$9.66K 0.08% 208
2025
Q1 		$251K Buy
3,615
+30
+0.8% +$2.48K 0.1% 192
2024
Q4 		$308K Sell
3,585
-1,204
-25% -$130K 0.11% 176
2024
Q3 		$570K Buy
4,789
+641
+15% +$85.5K 0.22% 105
2024
Q2 		$592K Sell
4,148
-1,811
-30% -$240K 0.25% 86
2024
Q1 		$765K Sell
5,959
-328
-5% -$39K 0.3% 73
2023
Q4 		$650K Sell
6,287
-105
-2% -$10.4K 0.26% 85
2023
Q3 		$581K Buy
6,392
+716
+13% +$63.1K 0.27% 85
2023
Q2 		$459K Sell
5,676
-106
-2% -$8.66K 0.19% 117
2023
Q1 		$460K Buy
5,782
+88
+2% +$6.24K 0.21% 111
2022
Q4 		$385K Sell
5,694
-210
-4% -$12.3K 0.18% 119
2022
Q3 		$294K Sell
5,904
-28
-0.5% -$1.5K 0.16% 137
2022
Q2 		$330K Buy
5,932
+1,390
+31% +$77.1K 0.18% 128
2022
Q1 		$252K Buy
4,542
+92
+2% +$4.72K 0.1% 189
2021
Q4 		$249K Sell
4,450
-58
-1% -$3.14K 0.1% 206
2021
Q3 		$216K Buy
+4,508
New +$218K 0.09% 219
2020
Q2 		– Sell
-11,766
Closed -$354K – 270
2020
Q1 		$354K Sell
11,766
-1,510
-11% -$45K 0.1% 137
2019
Q4 		$384K Buy
+13,276
New +$368K 0.1% 154

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Veracity Capital's NVO Position: Q3 2025 in Review

Veracity Capital sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,473 shares — an estimated $242K sold.

Veracity Capital first reported a position in NVO in Q4 2019 and held it in 18 quarters. The position peaked at $765K in Q1 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Veracity Capital reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Veracity Capital sold 3,473 Novo Nordisk shares in Q3 2025, an estimated $242K.
  • Veracity Capital first reported a position in Novo Nordisk in Q4 2019 and held it in 18 quarters.
  • Veracity Capital's Novo Nordisk position peaked at $765K in Q1 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Veracity Capital's 13F filing for Q3 2025, filed 8 Oct 2025.